nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP3A5—prostate cancer	0.161	0.473	CbGaD
Cilostazol—CYP2C19—prostate cancer	0.11	0.322	CbGaD
Cilostazol—CYP3A4—prostate cancer	0.0699	0.205	CbGaD
Cilostazol—CYP3A5—Flutamide—prostate cancer	0.0245	0.0607	CbGbCtD
Cilostazol—CYP2C19—Nilutamide—prostate cancer	0.0239	0.059	CbGbCtD
Cilostazol—CYP2C19—Bicalutamide—prostate cancer	0.0239	0.059	CbGbCtD
Cilostazol—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.022	0.0543	CbGbCtD
Cilostazol—CYP2C19—Flutamide—prostate cancer	0.0198	0.0489	CbGbCtD
Cilostazol—CYP1A2—Flutamide—prostate cancer	0.0183	0.0451	CbGbCtD
Cilostazol—CYP2D6—Bicalutamide—prostate cancer	0.0182	0.0449	CbGbCtD
Cilostazol—CYP3A5—Cabazitaxel—prostate cancer	0.0181	0.0449	CbGbCtD
Cilostazol—CYP3A5—Estrone—prostate cancer	0.0177	0.0439	CbGbCtD
Cilostazol—CYP2D6—Abiraterone—prostate cancer	0.015	0.0372	CbGbCtD
Cilostazol—CYP3A7—Estradiol—prostate cancer	0.0136	0.0336	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0136	0.0336	CbGbCtD
Cilostazol—CYP1A2—Estrone—prostate cancer	0.0132	0.0326	CbGbCtD
Cilostazol—CYP3A4—Bicalutamide—prostate cancer	0.0115	0.0285	CbGbCtD
Cilostazol—CYP3A4—Estramustine—prostate cancer	0.0107	0.0265	CbGbCtD
Cilostazol—CYP3A5—Estradiol—prostate cancer	0.0102	0.0252	CbGbCtD
Cilostazol—CYP3A4—Flutamide—prostate cancer	0.00956	0.0237	CbGbCtD
Cilostazol—CYP3A4—Abiraterone—prostate cancer	0.00956	0.0237	CbGbCtD
Cilostazol—CYP1A2—Conjugated Estrogens—prostate cancer	0.00863	0.0214	CbGbCtD
Cilostazol—CYP2C19—Estradiol—prostate cancer	0.00822	0.0203	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00811	0.0201	CbGbCtD
Cilostazol—CYP3A7—Docetaxel—prostate cancer	0.00811	0.0201	CbGbCtD
Cilostazol—CYP1A2—Estradiol—prostate cancer	0.00758	0.0187	CbGbCtD
Cilostazol—CYP3A4—Cabazitaxel—prostate cancer	0.00707	0.0175	CbGbCtD
Cilostazol—CYP2C19—Prednisone—prostate cancer	0.00706	0.0175	CbGbCtD
Cilostazol—CYP3A4—Estrone—prostate cancer	0.00691	0.0171	CbGbCtD
Cilostazol—CYP3A5—Etoposide—prostate cancer	0.00665	0.0164	CbGbCtD
Cilostazol—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00616	0.0152	CbGbCtD
Cilostazol—CYP3A5—Docetaxel—prostate cancer	0.00608	0.015	CbGbCtD
Cilostazol—PDE3A—penis—prostate cancer	0.00584	0.347	CbGeAlD
Cilostazol—CYP1A2—Etoposide—prostate cancer	0.00495	0.0122	CbGbCtD
Cilostazol—CYP3A4—Conjugated Estrogens—prostate cancer	0.00452	0.0112	CbGbCtD
Cilostazol—CYP3A4—Mitoxantrone—prostate cancer	0.00411	0.0102	CbGbCtD
Cilostazol—CYP3A4—Estradiol—prostate cancer	0.00397	0.00982	CbGbCtD
Cilostazol—CYP3A4—Prednisone—prostate cancer	0.00342	0.00845	CbGbCtD
Cilostazol—CYP2D6—Doxorubicin—prostate cancer	0.00278	0.00688	CbGbCtD
Cilostazol—CYP3A4—Etoposide—prostate cancer	0.00259	0.00641	CbGbCtD
Cilostazol—CYP3A4—Docetaxel—prostate cancer	0.00237	0.00587	CbGbCtD
Cilostazol—CYP2C19—urine—prostate cancer	0.00211	0.125	CbGeAlD
Cilostazol—CYP3A4—Doxorubicin—prostate cancer	0.00177	0.00437	CbGbCtD
Cilostazol—CYP1A2—urine—prostate cancer	0.00172	0.102	CbGeAlD
Cilostazol—PDE3A—prostate gland—prostate cancer	0.00139	0.083	CbGeAlD
Cilostazol—CYP3A4—urine—prostate cancer	0.00124	0.0741	CbGeAlD
Cilostazol—CYP2D6—urine—prostate cancer	0.00122	0.0729	CbGeAlD
Cilostazol—PDE3A—testis—prostate cancer	0.000614	0.0365	CbGeAlD
Cilostazol—CYP3A5—prostate gland—prostate cancer	0.000595	0.0354	CbGeAlD
Cilostazol—PDE3A—lymph node—prostate cancer	0.000445	0.0265	CbGeAlD
Cilostazol—CYP1A2—renal system—prostate cancer	0.000421	0.025	CbGeAlD
Cilostazol—CYP3A5—renal system—prostate cancer	0.000406	0.0241	CbGeAlD
Cilostazol—CYP3A4—renal system—prostate cancer	0.000305	0.0181	CbGeAlD
Cilostazol—CYP2D6—renal system—prostate cancer	0.0003	0.0178	CbGeAlD
Cilostazol—Aripiprazole—CYP3A5—prostate cancer	0.000289	0.698	CrCbGaD
Cilostazol—CYP2D6—testis—prostate cancer	0.000194	0.0115	CbGeAlD
Cilostazol—Aripiprazole—CYP3A4—prostate cancer	0.000125	0.302	CrCbGaD
Cilostazol—Nervous system disorder—Docetaxel—prostate cancer	3.48e-05	0.000219	CcSEcCtD
Cilostazol—Ill-defined disorder—Prednisone—prostate cancer	3.48e-05	0.000219	CcSEcCtD
Cilostazol—Thrombocytopenia—Docetaxel—prostate cancer	3.47e-05	0.000219	CcSEcCtD
Cilostazol—Rash—Estradiol—prostate cancer	3.47e-05	0.000219	CcSEcCtD
Cilostazol—Dermatitis—Estradiol—prostate cancer	3.47e-05	0.000219	CcSEcCtD
Cilostazol—Anaemia—Prednisone—prostate cancer	3.46e-05	0.000218	CcSEcCtD
Cilostazol—Tachycardia—Docetaxel—prostate cancer	3.46e-05	0.000218	CcSEcCtD
Cilostazol—Headache—Estradiol—prostate cancer	3.45e-05	0.000217	CcSEcCtD
Cilostazol—Skin disorder—Docetaxel—prostate cancer	3.44e-05	0.000217	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	3.44e-05	0.000217	CcSEcCtD
Cilostazol—Oedema—Capecitabine—prostate cancer	3.43e-05	0.000216	CcSEcCtD
Cilostazol—Infection—Capecitabine—prostate cancer	3.41e-05	0.000215	CcSEcCtD
Cilostazol—Urticaria—Etoposide—prostate cancer	3.39e-05	0.000214	CcSEcCtD
Cilostazol—Haemoglobin—Epirubicin—prostate cancer	3.38e-05	0.000213	CcSEcCtD
Cilostazol—Jaundice—Doxorubicin—prostate cancer	3.38e-05	0.000213	CcSEcCtD
Cilostazol—Anorexia—Docetaxel—prostate cancer	3.38e-05	0.000213	CcSEcCtD
Cilostazol—Malaise—Prednisone—prostate cancer	3.38e-05	0.000213	CcSEcCtD
Cilostazol—Shock—Capecitabine—prostate cancer	3.38e-05	0.000213	CcSEcCtD
Cilostazol—Rhinitis—Epirubicin—prostate cancer	3.37e-05	0.000213	CcSEcCtD
Cilostazol—Body temperature increased—Etoposide—prostate cancer	3.37e-05	0.000213	CcSEcCtD
Cilostazol—Abdominal pain—Etoposide—prostate cancer	3.37e-05	0.000213	CcSEcCtD
Cilostazol—Conjunctivitis—Doxorubicin—prostate cancer	3.37e-05	0.000213	CcSEcCtD
Cilostazol—Urinary tract infection—Doxorubicin—prostate cancer	3.37e-05	0.000213	CcSEcCtD
Cilostazol—Nervous system disorder—Capecitabine—prostate cancer	3.37e-05	0.000212	CcSEcCtD
Cilostazol—Vertigo—Prednisone—prostate cancer	3.37e-05	0.000212	CcSEcCtD
Cilostazol—Haemorrhage—Epirubicin—prostate cancer	3.37e-05	0.000212	CcSEcCtD
Cilostazol—Thrombocytopenia—Capecitabine—prostate cancer	3.36e-05	0.000212	CcSEcCtD
Cilostazol—Syncope—Prednisone—prostate cancer	3.36e-05	0.000212	CcSEcCtD
Cilostazol—Tachycardia—Capecitabine—prostate cancer	3.35e-05	0.000211	CcSEcCtD
Cilostazol—Hypoaesthesia—Epirubicin—prostate cancer	3.35e-05	0.000211	CcSEcCtD
Cilostazol—Pharyngitis—Epirubicin—prostate cancer	3.34e-05	0.000211	CcSEcCtD
Cilostazol—Skin disorder—Capecitabine—prostate cancer	3.33e-05	0.00021	CcSEcCtD
Cilostazol—Oedema peripheral—Epirubicin—prostate cancer	3.32e-05	0.000209	CcSEcCtD
Cilostazol—Hypotension—Docetaxel—prostate cancer	3.31e-05	0.000209	CcSEcCtD
Cilostazol—Haematuria—Doxorubicin—prostate cancer	3.31e-05	0.000209	CcSEcCtD
Cilostazol—Loss of consciousness—Prednisone—prostate cancer	3.29e-05	0.000208	CcSEcCtD
Cilostazol—Hepatobiliary disease—Doxorubicin—prostate cancer	3.28e-05	0.000207	CcSEcCtD
Cilostazol—Epistaxis—Doxorubicin—prostate cancer	3.27e-05	0.000206	CcSEcCtD
Cilostazol—Anorexia—Capecitabine—prostate cancer	3.27e-05	0.000206	CcSEcCtD
Cilostazol—Nausea—Estradiol—prostate cancer	3.27e-05	0.000206	CcSEcCtD
Cilostazol—Vomiting—Mitoxantrone—prostate cancer	3.26e-05	0.000206	CcSEcCtD
Cilostazol—Sinusitis—Doxorubicin—prostate cancer	3.25e-05	0.000205	CcSEcCtD
Cilostazol—Agranulocytosis—Doxorubicin—prostate cancer	3.24e-05	0.000204	CcSEcCtD
Cilostazol—Hypertension—Prednisone—prostate cancer	3.23e-05	0.000204	CcSEcCtD
Cilostazol—Rash—Mitoxantrone—prostate cancer	3.23e-05	0.000204	CcSEcCtD
Cilostazol—Dermatitis—Mitoxantrone—prostate cancer	3.23e-05	0.000204	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.23e-05	0.000204	CcSEcCtD
Cilostazol—Headache—Mitoxantrone—prostate cancer	3.21e-05	0.000203	CcSEcCtD
Cilostazol—Hypotension—Capecitabine—prostate cancer	3.21e-05	0.000202	CcSEcCtD
Cilostazol—Insomnia—Docetaxel—prostate cancer	3.21e-05	0.000202	CcSEcCtD
Cilostazol—Myalgia—Prednisone—prostate cancer	3.19e-05	0.000201	CcSEcCtD
Cilostazol—Arthralgia—Prednisone—prostate cancer	3.19e-05	0.000201	CcSEcCtD
Cilostazol—Paraesthesia—Docetaxel—prostate cancer	3.18e-05	0.000201	CcSEcCtD
Cilostazol—Erythema multiforme—Epirubicin—prostate cancer	3.18e-05	0.000201	CcSEcCtD
Cilostazol—Anxiety—Prednisone—prostate cancer	3.18e-05	0.0002	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.17e-05	0.0002	CcSEcCtD
Cilostazol—Dyspnoea—Docetaxel—prostate cancer	3.16e-05	0.000199	CcSEcCtD
Cilostazol—Discomfort—Prednisone—prostate cancer	3.15e-05	0.000199	CcSEcCtD
Cilostazol—Tinnitus—Epirubicin—prostate cancer	3.14e-05	0.000198	CcSEcCtD
Cilostazol—Haemoglobin—Doxorubicin—prostate cancer	3.13e-05	0.000197	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.13e-05	0.000197	CcSEcCtD
Cilostazol—Cardiac disorder—Epirubicin—prostate cancer	3.12e-05	0.000197	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—prostate cancer	3.12e-05	0.000197	CcSEcCtD
Cilostazol—Dyspepsia—Docetaxel—prostate cancer	3.12e-05	0.000197	CcSEcCtD
Cilostazol—Haemorrhage—Doxorubicin—prostate cancer	3.11e-05	0.000196	CcSEcCtD
Cilostazol—Insomnia—Capecitabine—prostate cancer	3.1e-05	0.000196	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—prostate cancer	3.1e-05	0.000195	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—prostate cancer	3.09e-05	0.000195	CcSEcCtD
Cilostazol—Paraesthesia—Capecitabine—prostate cancer	3.08e-05	0.000194	CcSEcCtD
Cilostazol—Decreased appetite—Docetaxel—prostate cancer	3.08e-05	0.000194	CcSEcCtD
Cilostazol—Oedema peripheral—Doxorubicin—prostate cancer	3.07e-05	0.000193	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Docetaxel—prostate cancer	3.06e-05	0.000193	CcSEcCtD
Cilostazol—Asthenia—Etoposide—prostate cancer	3.06e-05	0.000193	CcSEcCtD
Cilostazol—Dyspnoea—Capecitabine—prostate cancer	3.06e-05	0.000193	CcSEcCtD
Cilostazol—Oedema—Prednisone—prostate cancer	3.06e-05	0.000193	CcSEcCtD
Cilostazol—Angiopathy—Epirubicin—prostate cancer	3.05e-05	0.000193	CcSEcCtD
Cilostazol—Nausea—Mitoxantrone—prostate cancer	3.05e-05	0.000192	CcSEcCtD
Cilostazol—Infection—Prednisone—prostate cancer	3.04e-05	0.000192	CcSEcCtD
Cilostazol—Mediastinal disorder—Epirubicin—prostate cancer	3.03e-05	0.000191	CcSEcCtD
Cilostazol—Pain—Docetaxel—prostate cancer	3.03e-05	0.000191	CcSEcCtD
Cilostazol—Dyspepsia—Capecitabine—prostate cancer	3.02e-05	0.000191	CcSEcCtD
Cilostazol—Chills—Epirubicin—prostate cancer	3.02e-05	0.00019	CcSEcCtD
Cilostazol—Pruritus—Etoposide—prostate cancer	3.02e-05	0.00019	CcSEcCtD
Cilostazol—Shock—Prednisone—prostate cancer	3.01e-05	0.00019	CcSEcCtD
Cilostazol—Nervous system disorder—Prednisone—prostate cancer	3e-05	0.000189	CcSEcCtD
Cilostazol—Tachycardia—Prednisone—prostate cancer	2.98e-05	0.000188	CcSEcCtD
Cilostazol—Decreased appetite—Capecitabine—prostate cancer	2.98e-05	0.000188	CcSEcCtD
Cilostazol—Skin disorder—Prednisone—prostate cancer	2.97e-05	0.000187	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Capecitabine—prostate cancer	2.96e-05	0.000187	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—prostate cancer	2.94e-05	0.000186	CcSEcCtD
Cilostazol—Pain—Capecitabine—prostate cancer	2.94e-05	0.000185	CcSEcCtD
Cilostazol—Feeling abnormal—Docetaxel—prostate cancer	2.92e-05	0.000184	CcSEcCtD
Cilostazol—Diarrhoea—Etoposide—prostate cancer	2.92e-05	0.000184	CcSEcCtD
Cilostazol—Anorexia—Prednisone—prostate cancer	2.91e-05	0.000184	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—prostate cancer	2.9e-05	0.000183	CcSEcCtD
Cilostazol—Gastrointestinal pain—Docetaxel—prostate cancer	2.9e-05	0.000183	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—prostate cancer	2.89e-05	0.000182	CcSEcCtD
Cilostazol—Flatulence—Epirubicin—prostate cancer	2.89e-05	0.000182	CcSEcCtD
Cilostazol—Back pain—Epirubicin—prostate cancer	2.83e-05	0.000179	CcSEcCtD
Cilostazol—Feeling abnormal—Capecitabine—prostate cancer	2.83e-05	0.000178	CcSEcCtD
Cilostazol—Angiopathy—Doxorubicin—prostate cancer	2.83e-05	0.000178	CcSEcCtD
Cilostazol—Dizziness—Etoposide—prostate cancer	2.82e-05	0.000178	CcSEcCtD
Cilostazol—Muscle spasms—Epirubicin—prostate cancer	2.82e-05	0.000178	CcSEcCtD
Cilostazol—Gastrointestinal pain—Capecitabine—prostate cancer	2.81e-05	0.000177	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—prostate cancer	2.81e-05	0.000177	CcSEcCtD
Cilostazol—Abdominal pain—Docetaxel—prostate cancer	2.8e-05	0.000177	CcSEcCtD
Cilostazol—Body temperature increased—Docetaxel—prostate cancer	2.8e-05	0.000177	CcSEcCtD
Cilostazol—Chills—Doxorubicin—prostate cancer	2.79e-05	0.000176	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Prednisone—prostate cancer	2.79e-05	0.000176	CcSEcCtD
Cilostazol—Insomnia—Prednisone—prostate cancer	2.77e-05	0.000174	CcSEcCtD
Cilostazol—Paraesthesia—Prednisone—prostate cancer	2.75e-05	0.000173	CcSEcCtD
Cilostazol—Urticaria—Capecitabine—prostate cancer	2.73e-05	0.000172	CcSEcCtD
Cilostazol—Ill-defined disorder—Epirubicin—prostate cancer	2.72e-05	0.000171	CcSEcCtD
Cilostazol—Abdominal pain—Capecitabine—prostate cancer	2.71e-05	0.000171	CcSEcCtD
Cilostazol—Body temperature increased—Capecitabine—prostate cancer	2.71e-05	0.000171	CcSEcCtD
Cilostazol—Vomiting—Etoposide—prostate cancer	2.71e-05	0.000171	CcSEcCtD
Cilostazol—Anaemia—Epirubicin—prostate cancer	2.71e-05	0.000171	CcSEcCtD
Cilostazol—Dyspepsia—Prednisone—prostate cancer	2.69e-05	0.00017	CcSEcCtD
Cilostazol—Rash—Etoposide—prostate cancer	2.69e-05	0.00017	CcSEcCtD
Cilostazol—Dermatitis—Etoposide—prostate cancer	2.69e-05	0.000169	CcSEcCtD
Cilostazol—Headache—Etoposide—prostate cancer	2.67e-05	0.000169	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—prostate cancer	2.67e-05	0.000168	CcSEcCtD
Cilostazol—Decreased appetite—Prednisone—prostate cancer	2.66e-05	0.000168	CcSEcCtD
Cilostazol—Malaise—Epirubicin—prostate cancer	2.64e-05	0.000167	CcSEcCtD
Cilostazol—Vertigo—Epirubicin—prostate cancer	2.63e-05	0.000166	CcSEcCtD
Cilostazol—Syncope—Epirubicin—prostate cancer	2.63e-05	0.000166	CcSEcCtD
Cilostazol—Leukopenia—Epirubicin—prostate cancer	2.62e-05	0.000165	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—prostate cancer	2.62e-05	0.000165	CcSEcCtD
Cilostazol—Muscle spasms—Doxorubicin—prostate cancer	2.61e-05	0.000164	CcSEcCtD
Cilostazol—Palpitations—Epirubicin—prostate cancer	2.59e-05	0.000163	CcSEcCtD
Cilostazol—Loss of consciousness—Epirubicin—prostate cancer	2.58e-05	0.000162	CcSEcCtD
Cilostazol—Cough—Epirubicin—prostate cancer	2.56e-05	0.000161	CcSEcCtD
Cilostazol—Asthenia—Docetaxel—prostate cancer	2.54e-05	0.00016	CcSEcCtD
Cilostazol—Nausea—Etoposide—prostate cancer	2.53e-05	0.00016	CcSEcCtD
Cilostazol—Hypertension—Epirubicin—prostate cancer	2.53e-05	0.00016	CcSEcCtD
Cilostazol—Feeling abnormal—Prednisone—prostate cancer	2.52e-05	0.000159	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—prostate cancer	2.52e-05	0.000159	CcSEcCtD
Cilostazol—Pruritus—Docetaxel—prostate cancer	2.51e-05	0.000158	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—prostate cancer	2.51e-05	0.000158	CcSEcCtD
Cilostazol—Gastrointestinal pain—Prednisone—prostate cancer	2.5e-05	0.000158	CcSEcCtD
Cilostazol—Myalgia—Epirubicin—prostate cancer	2.49e-05	0.000157	CcSEcCtD
Cilostazol—Chest pain—Epirubicin—prostate cancer	2.49e-05	0.000157	CcSEcCtD
Cilostazol—Arthralgia—Epirubicin—prostate cancer	2.49e-05	0.000157	CcSEcCtD
Cilostazol—Anxiety—Epirubicin—prostate cancer	2.49e-05	0.000157	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.48e-05	0.000156	CcSEcCtD
Cilostazol—Discomfort—Epirubicin—prostate cancer	2.46e-05	0.000155	CcSEcCtD
Cilostazol—Asthenia—Capecitabine—prostate cancer	2.46e-05	0.000155	CcSEcCtD
Cilostazol—Malaise—Doxorubicin—prostate cancer	2.44e-05	0.000154	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—prostate cancer	2.44e-05	0.000154	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—prostate cancer	2.43e-05	0.000153	CcSEcCtD
Cilostazol—Urticaria—Prednisone—prostate cancer	2.43e-05	0.000153	CcSEcCtD
Cilostazol—Pruritus—Capecitabine—prostate cancer	2.43e-05	0.000153	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—prostate cancer	2.43e-05	0.000153	CcSEcCtD
Cilostazol—Diarrhoea—Docetaxel—prostate cancer	2.43e-05	0.000153	CcSEcCtD
Cilostazol—Body temperature increased—Prednisone—prostate cancer	2.42e-05	0.000152	CcSEcCtD
Cilostazol—Abdominal pain—Prednisone—prostate cancer	2.42e-05	0.000152	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—prostate cancer	2.4e-05	0.000151	CcSEcCtD
Cilostazol—Oedema—Epirubicin—prostate cancer	2.39e-05	0.000151	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—prostate cancer	2.38e-05	0.00015	CcSEcCtD
Cilostazol—Infection—Epirubicin—prostate cancer	2.38e-05	0.00015	CcSEcCtD
Cilostazol—Cough—Doxorubicin—prostate cancer	2.37e-05	0.000149	CcSEcCtD
Cilostazol—Shock—Epirubicin—prostate cancer	2.35e-05	0.000148	CcSEcCtD
Cilostazol—Diarrhoea—Capecitabine—prostate cancer	2.35e-05	0.000148	CcSEcCtD
Cilostazol—Nervous system disorder—Epirubicin—prostate cancer	2.34e-05	0.000148	CcSEcCtD
Cilostazol—Dizziness—Docetaxel—prostate cancer	2.34e-05	0.000148	CcSEcCtD
Cilostazol—Thrombocytopenia—Epirubicin—prostate cancer	2.34e-05	0.000148	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—prostate cancer	2.34e-05	0.000148	CcSEcCtD
Cilostazol—Tachycardia—Epirubicin—prostate cancer	2.33e-05	0.000147	CcSEcCtD
Cilostazol—Skin disorder—Epirubicin—prostate cancer	2.32e-05	0.000146	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—prostate cancer	2.31e-05	0.000146	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—prostate cancer	2.31e-05	0.000146	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—prostate cancer	2.31e-05	0.000146	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—prostate cancer	2.3e-05	0.000145	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.29e-05	0.000145	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—prostate cancer	2.28e-05	0.000144	CcSEcCtD
Cilostazol—Anorexia—Epirubicin—prostate cancer	2.28e-05	0.000144	CcSEcCtD
Cilostazol—Dizziness—Capecitabine—prostate cancer	2.27e-05	0.000143	CcSEcCtD
Cilostazol—Vomiting—Docetaxel—prostate cancer	2.25e-05	0.000142	CcSEcCtD
Cilostazol—Rash—Docetaxel—prostate cancer	2.24e-05	0.000141	CcSEcCtD
Cilostazol—Hypotension—Epirubicin—prostate cancer	2.23e-05	0.000141	CcSEcCtD
Cilostazol—Dermatitis—Docetaxel—prostate cancer	2.23e-05	0.000141	CcSEcCtD
Cilostazol—Headache—Docetaxel—prostate cancer	2.22e-05	0.00014	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—prostate cancer	2.21e-05	0.00014	CcSEcCtD
Cilostazol—Infection—Doxorubicin—prostate cancer	2.2e-05	0.000139	CcSEcCtD
Cilostazol—Asthenia—Prednisone—prostate cancer	2.19e-05	0.000138	CcSEcCtD
Cilostazol—Vomiting—Capecitabine—prostate cancer	2.18e-05	0.000138	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.18e-05	0.000137	CcSEcCtD
Cilostazol—Shock—Doxorubicin—prostate cancer	2.18e-05	0.000137	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—prostate cancer	2.17e-05	0.000137	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—prostate cancer	2.17e-05	0.000137	CcSEcCtD
Cilostazol—Rash—Capecitabine—prostate cancer	2.16e-05	0.000136	CcSEcCtD
Cilostazol—Pruritus—Prednisone—prostate cancer	2.16e-05	0.000136	CcSEcCtD
Cilostazol—Insomnia—Epirubicin—prostate cancer	2.16e-05	0.000136	CcSEcCtD
Cilostazol—Dermatitis—Capecitabine—prostate cancer	2.16e-05	0.000136	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—prostate cancer	2.16e-05	0.000136	CcSEcCtD
Cilostazol—Headache—Capecitabine—prostate cancer	2.15e-05	0.000136	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—prostate cancer	2.15e-05	0.000136	CcSEcCtD
Cilostazol—Paraesthesia—Epirubicin—prostate cancer	2.15e-05	0.000135	CcSEcCtD
Cilostazol—Dyspnoea—Epirubicin—prostate cancer	2.13e-05	0.000134	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—prostate cancer	2.11e-05	0.000133	CcSEcCtD
Cilostazol—Nausea—Docetaxel—prostate cancer	2.11e-05	0.000133	CcSEcCtD
Cilostazol—Dyspepsia—Epirubicin—prostate cancer	2.1e-05	0.000133	CcSEcCtD
Cilostazol—Diarrhoea—Prednisone—prostate cancer	2.09e-05	0.000132	CcSEcCtD
Cilostazol—Decreased appetite—Epirubicin—prostate cancer	2.08e-05	0.000131	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—prostate cancer	2.07e-05	0.00013	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Epirubicin—prostate cancer	2.06e-05	0.00013	CcSEcCtD
Cilostazol—Pain—Epirubicin—prostate cancer	2.04e-05	0.000129	CcSEcCtD
Cilostazol—Nausea—Capecitabine—prostate cancer	2.04e-05	0.000129	CcSEcCtD
Cilostazol—Dizziness—Prednisone—prostate cancer	2.02e-05	0.000127	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.02e-05	0.000127	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—prostate cancer	2e-05	0.000126	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—prostate cancer	1.99e-05	0.000125	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—prostate cancer	1.97e-05	0.000124	CcSEcCtD
Cilostazol—Feeling abnormal—Epirubicin—prostate cancer	1.97e-05	0.000124	CcSEcCtD
Cilostazol—Gastrointestinal pain—Epirubicin—prostate cancer	1.96e-05	0.000123	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—prostate cancer	1.95e-05	0.000123	CcSEcCtD
Cilostazol—Vomiting—Prednisone—prostate cancer	1.94e-05	0.000123	CcSEcCtD
Cilostazol—Rash—Prednisone—prostate cancer	1.93e-05	0.000122	CcSEcCtD
Cilostazol—Dermatitis—Prednisone—prostate cancer	1.93e-05	0.000121	CcSEcCtD
Cilostazol—Decreased appetite—Doxorubicin—prostate cancer	1.92e-05	0.000121	CcSEcCtD
Cilostazol—Headache—Prednisone—prostate cancer	1.92e-05	0.000121	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.91e-05	0.00012	CcSEcCtD
Cilostazol—Urticaria—Epirubicin—prostate cancer	1.9e-05	0.00012	CcSEcCtD
Cilostazol—Pain—Doxorubicin—prostate cancer	1.89e-05	0.000119	CcSEcCtD
Cilostazol—Body temperature increased—Epirubicin—prostate cancer	1.89e-05	0.000119	CcSEcCtD
Cilostazol—Abdominal pain—Epirubicin—prostate cancer	1.89e-05	0.000119	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—prostate cancer	1.82e-05	0.000115	CcSEcCtD
Cilostazol—Nausea—Prednisone—prostate cancer	1.82e-05	0.000115	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—prostate cancer	1.81e-05	0.000114	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—prostate cancer	1.76e-05	0.000111	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—prostate cancer	1.75e-05	0.00011	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—prostate cancer	1.75e-05	0.00011	CcSEcCtD
Cilostazol—Asthenia—Epirubicin—prostate cancer	1.72e-05	0.000108	CcSEcCtD
Cilostazol—Pruritus—Epirubicin—prostate cancer	1.69e-05	0.000107	CcSEcCtD
Cilostazol—Diarrhoea—Epirubicin—prostate cancer	1.64e-05	0.000103	CcSEcCtD
Cilostazol—Asthenia—Doxorubicin—prostate cancer	1.59e-05	0.0001	CcSEcCtD
Cilostazol—Dizziness—Epirubicin—prostate cancer	1.58e-05	9.97e-05	CcSEcCtD
Cilostazol—Pruritus—Doxorubicin—prostate cancer	1.57e-05	9.87e-05	CcSEcCtD
Cilostazol—Vomiting—Epirubicin—prostate cancer	1.52e-05	9.59e-05	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—prostate cancer	1.51e-05	9.55e-05	CcSEcCtD
Cilostazol—Rash—Epirubicin—prostate cancer	1.51e-05	9.51e-05	CcSEcCtD
Cilostazol—Dermatitis—Epirubicin—prostate cancer	1.51e-05	9.5e-05	CcSEcCtD
Cilostazol—Headache—Epirubicin—prostate cancer	1.5e-05	9.45e-05	CcSEcCtD
Cilostazol—Dizziness—Doxorubicin—prostate cancer	1.46e-05	9.23e-05	CcSEcCtD
Cilostazol—Nausea—Epirubicin—prostate cancer	1.42e-05	8.96e-05	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—prostate cancer	1.41e-05	8.87e-05	CcSEcCtD
Cilostazol—Rash—Doxorubicin—prostate cancer	1.4e-05	8.8e-05	CcSEcCtD
Cilostazol—Dermatitis—Doxorubicin—prostate cancer	1.39e-05	8.79e-05	CcSEcCtD
Cilostazol—Headache—Doxorubicin—prostate cancer	1.39e-05	8.74e-05	CcSEcCtD
Cilostazol—Nausea—Doxorubicin—prostate cancer	1.31e-05	8.29e-05	CcSEcCtD
Cilostazol—CYP2C19—Metabolism—PRKACB—prostate cancer	3.97e-06	5.04e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HPGDS—prostate cancer	3.93e-06	5e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP17A1—prostate cancer	3.92e-06	4.99e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—P4HB—prostate cancer	3.92e-06	4.98e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.92e-06	4.98e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EP300—prostate cancer	3.91e-06	4.97e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2C19—prostate cancer	3.91e-06	4.97e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—RXRA—prostate cancer	3.88e-06	4.93e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.87e-06	4.92e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CAV1—prostate cancer	3.85e-06	4.9e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ACHE—prostate cancer	3.81e-06	4.85e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTT1—prostate cancer	3.81e-06	4.85e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC22A1—prostate cancer	3.81e-06	4.84e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SRC—prostate cancer	3.8e-06	4.83e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PDHA1—prostate cancer	3.78e-06	4.81e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TCN2—prostate cancer	3.78e-06	4.81e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—UCP3—prostate cancer	3.78e-06	4.81e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA3—prostate cancer	3.78e-06	4.81e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2A6—prostate cancer	3.77e-06	4.79e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.77e-06	4.79e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NCOA2—prostate cancer	3.74e-06	4.75e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—COMT—prostate cancer	3.73e-06	4.75e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTP1—prostate cancer	3.72e-06	4.72e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SULT2A1—prostate cancer	3.71e-06	4.72e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VEGFA—prostate cancer	3.7e-06	4.71e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—STAT3—prostate cancer	3.67e-06	4.66e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AKR1C3—prostate cancer	3.67e-06	4.66e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ITPR1—prostate cancer	3.66e-06	4.65e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MED12—prostate cancer	3.65e-06	4.64e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PRKACB—prostate cancer	3.65e-06	4.64e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GNG5—prostate cancer	3.62e-06	4.61e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP17A1—prostate cancer	3.61e-06	4.59e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.61e-06	4.58e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.61e-06	4.58e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC5A5—prostate cancer	3.57e-06	4.53e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CG—prostate cancer	3.51e-06	4.46e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOA3—prostate cancer	3.49e-06	4.44e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2E1—prostate cancer	3.48e-06	4.43e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.46e-06	4.4e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA4—prostate cancer	3.46e-06	4.4e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TYMS—prostate cancer	3.46e-06	4.39e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NQO1—prostate cancer	3.45e-06	4.38e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NCOA2—prostate cancer	3.44e-06	4.37e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.43e-06	4.36e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTM1—prostate cancer	3.42e-06	4.34e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MYC—prostate cancer	3.41e-06	4.33e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TGFB1—prostate cancer	3.4e-06	4.32e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TH—prostate cancer	3.4e-06	4.32e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.37e-06	4.29e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA2—prostate cancer	3.37e-06	4.28e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP3A4—prostate cancer	3.36e-06	4.27e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—LPL—prostate cancer	3.35e-06	4.26e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.34e-06	4.25e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EGFR—prostate cancer	3.33e-06	4.24e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HPGDS—prostate cancer	3.33e-06	4.23e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.33e-06	4.23e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCG5—prostate cancer	3.33e-06	4.23e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—INS—prostate cancer	3.32e-06	4.22e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.31e-06	4.21e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP1B1—prostate cancer	3.3e-06	4.2e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC5A5—prostate cancer	3.28e-06	4.17e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CREBBP—prostate cancer	3.25e-06	4.13e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA1—prostate cancer	3.25e-06	4.13e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP1A1—prostate cancer	3.24e-06	4.12e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTT1—prostate cancer	3.23e-06	4.11e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ACHE—prostate cancer	3.23e-06	4.11e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.22e-06	4.09e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTO1—prostate cancer	3.22e-06	4.09e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NAT2—prostate cancer	3.22e-06	4.09e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ERCC2—prostate cancer	3.21e-06	4.08e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2E1—prostate cancer	3.2e-06	4.07e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GGT1—prostate cancer	3.2e-06	4.07e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.19e-06	4.06e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.18e-06	4.04e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NQO1—prostate cancer	3.17e-06	4.03e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NCOA1—prostate cancer	3.15e-06	4.01e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KRAS—prostate cancer	3.15e-06	4e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TH—prostate cancer	3.12e-06	3.97e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AKR1C3—prostate cancer	3.11e-06	3.95e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP19A1—prostate cancer	3.11e-06	3.95e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP3A4—prostate cancer	3.09e-06	3.93e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PRKACB—prostate cancer	3.09e-06	3.93e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CD—prostate cancer	3.08e-06	3.92e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PLCB2—prostate cancer	3.08e-06	3.92e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—LRP2—prostate cancer	3.08e-06	3.92e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.08e-06	3.92e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP17A1—prostate cancer	3.06e-06	3.89e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP1B1—prostate cancer	3.04e-06	3.86e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—P4HB—prostate cancer	3.02e-06	3.84e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MTHFR—prostate cancer	3.02e-06	3.84e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.02e-06	3.83e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—RXRA—prostate cancer	3e-06	3.81e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PPARA—prostate cancer	2.96e-06	3.76e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GGT1—prostate cancer	2.94e-06	3.74e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.94e-06	3.74e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.92e-06	3.71e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOA2—prostate cancer	2.91e-06	3.7e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NOS3—prostate cancer	2.91e-06	3.7e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NCOA1—prostate cancer	2.9e-06	3.68e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CA—prostate cancer	2.89e-06	3.68e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—COMT—prostate cancer	2.89e-06	3.67e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTP1—prostate cancer	2.87e-06	3.65e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.87e-06	3.64e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.86e-06	3.63e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ITPR1—prostate cancer	2.83e-06	3.59e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MED12—prostate cancer	2.82e-06	3.58e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—prostate cancer	2.8e-06	3.56e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GNG5—prostate cancer	2.8e-06	3.56e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CAV1—prostate cancer	2.78e-06	3.54e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.78e-06	3.53e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.78e-06	3.53e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—RXRA—prostate cancer	2.76e-06	3.5e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.71e-06	3.45e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOA3—prostate cancer	2.69e-06	3.42e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CB—prostate cancer	2.69e-06	3.42e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NQO1—prostate cancer	2.68e-06	3.41e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TYMS—prostate cancer	2.67e-06	3.4e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS2—prostate cancer	2.66e-06	3.39e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—COMT—prostate cancer	2.66e-06	3.38e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TH—prostate cancer	2.65e-06	3.36e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTP1—prostate cancer	2.64e-06	3.36e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTM1—prostate cancer	2.64e-06	3.36e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.63e-06	3.34e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.62e-06	3.33e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.6e-06	3.31e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ITPR1—prostate cancer	2.6e-06	3.31e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—LPL—prostate cancer	2.59e-06	3.29e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.57e-06	3.27e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HPGDS—prostate cancer	2.57e-06	3.27e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL6—prostate cancer	2.56e-06	3.26e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.55e-06	3.25e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CG—prostate cancer	2.54e-06	3.22e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.5e-06	3.18e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ACHE—prostate cancer	2.49e-06	3.17e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTT1—prostate cancer	2.49e-06	3.17e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GGT1—prostate cancer	2.49e-06	3.17e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ERCC2—prostate cancer	2.48e-06	3.16e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.46e-06	3.13e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TYMS—prostate cancer	2.46e-06	3.12e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOA1—prostate cancer	2.46e-06	3.12e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTM1—prostate cancer	2.43e-06	3.09e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.42e-06	3.08e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—INS—prostate cancer	2.4e-06	3.05e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.4e-06	3.05e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PRKACB—prostate cancer	2.38e-06	3.03e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—LPL—prostate cancer	2.38e-06	3.03e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—AKT1—prostate cancer	2.36e-06	3e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.36e-06	3e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CREBBP—prostate cancer	2.35e-06	2.99e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—RXRA—prostate cancer	2.34e-06	2.97e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MTHFR—prostate cancer	2.33e-06	2.97e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTEN—prostate cancer	2.32e-06	2.95e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.3e-06	2.93e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PPARA—prostate cancer	2.29e-06	2.91e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ERCC2—prostate cancer	2.28e-06	2.9e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.27e-06	2.89e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—COMT—prostate cancer	2.25e-06	2.86e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOA2—prostate cancer	2.25e-06	2.86e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTP1—prostate cancer	2.24e-06	2.85e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.23e-06	2.83e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—EP300—prostate cancer	2.22e-06	2.82e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ITPR1—prostate cancer	2.2e-06	2.8e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.17e-06	2.75e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CAV1—prostate cancer	2.15e-06	2.74e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MTHFR—prostate cancer	2.15e-06	2.73e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.15e-06	2.73e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPARA—prostate cancer	2.11e-06	2.68e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NOS3—prostate cancer	2.11e-06	2.68e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.1e-06	2.66e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TYMS—prostate cancer	2.08e-06	2.65e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NQO1—prostate cancer	2.07e-06	2.63e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTM1—prostate cancer	2.06e-06	2.62e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.06e-06	2.61e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TH—prostate cancer	2.04e-06	2.6e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—LPL—prostate cancer	2.02e-06	2.57e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.99e-06	2.52e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CAV1—prostate cancer	1.98e-06	2.52e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.96e-06	2.49e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.95e-06	2.48e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.94e-06	2.47e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ERCC2—prostate cancer	1.93e-06	2.46e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS2—prostate cancer	1.93e-06	2.45e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GGT1—prostate cancer	1.92e-06	2.45e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOA1—prostate cancer	1.89e-06	2.41e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.87e-06	2.37e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—INS—prostate cancer	1.86e-06	2.36e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MTHFR—prostate cancer	1.82e-06	2.31e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CREBBP—prostate cancer	1.82e-06	2.31e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.8e-06	2.29e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—RXRA—prostate cancer	1.8e-06	2.29e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPARA—prostate cancer	1.78e-06	2.27e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—COMT—prostate cancer	1.74e-06	2.21e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTP1—prostate cancer	1.73e-06	2.2e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.72e-06	2.19e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—INS—prostate cancer	1.71e-06	2.17e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ITPR1—prostate cancer	1.7e-06	2.16e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTEN—prostate cancer	1.68e-06	2.13e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CAV1—prostate cancer	1.68e-06	2.13e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CREBBP—prostate cancer	1.67e-06	2.13e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.64e-06	2.08e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NOS3—prostate cancer	1.63e-06	2.07e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TYMS—prostate cancer	1.61e-06	2.04e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.6e-06	2.04e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—EP300—prostate cancer	1.6e-06	2.04e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTM1—prostate cancer	1.59e-06	2.02e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.59e-06	2.02e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—LPL—prostate cancer	1.56e-06	1.98e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.53e-06	1.94e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.51e-06	1.91e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.5e-06	1.91e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NOS3—prostate cancer	1.5e-06	1.9e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ERCC2—prostate cancer	1.49e-06	1.9e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS2—prostate cancer	1.49e-06	1.89e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—INS—prostate cancer	1.45e-06	1.84e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CREBBP—prostate cancer	1.42e-06	1.8e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTHFR—prostate cancer	1.4e-06	1.78e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.38e-06	1.76e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPARA—prostate cancer	1.38e-06	1.75e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS2—prostate cancer	1.37e-06	1.74e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.34e-06	1.71e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—AKT1—prostate cancer	1.34e-06	1.7e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTEN—prostate cancer	1.3e-06	1.65e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CAV1—prostate cancer	1.29e-06	1.65e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NOS3—prostate cancer	1.27e-06	1.61e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—EP300—prostate cancer	1.24e-06	1.57e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTEN—prostate cancer	1.19e-06	1.52e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.18e-06	1.51e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.18e-06	1.5e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.17e-06	1.49e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS2—prostate cancer	1.16e-06	1.47e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—EP300—prostate cancer	1.14e-06	1.45e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—INS—prostate cancer	1.12e-06	1.42e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CREBBP—prostate cancer	1.09e-06	1.39e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.04e-06	1.32e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTEN—prostate cancer	1.01e-06	1.29e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NOS3—prostate cancer	9.79e-07	1.24e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—AKT1—prostate cancer	9.68e-07	1.23e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—EP300—prostate cancer	9.65e-07	1.23e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CA—prostate cancer	9.16e-07	1.16e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CB—prostate cancer	9.03e-07	1.15e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS2—prostate cancer	8.95e-07	1.14e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CA—prostate cancer	8.42e-07	1.07e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTEN—prostate cancer	7.81e-07	9.92e-06	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—AKT1—prostate cancer	7.48e-07	9.51e-06	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—EP300—prostate cancer	7.45e-07	9.46e-06	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CA—prostate cancer	7.14e-07	9.07e-06	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AKT1—prostate cancer	6.88e-07	8.75e-06	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AKT1—prostate cancer	5.83e-07	7.41e-06	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.51e-07	7e-06	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AKT1—prostate cancer	4.5e-07	5.72e-06	CbGpPWpGaD
